Citigroup Inc. Trims Stock Holdings in National Health Investors, Inc. $NHI

Citigroup Inc. cut its holdings in shares of National Health Investors, Inc. (NYSE:NHI) by 26.9% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 52,838 shares of the real estate investment trust’s stock after selling 19,465 shares during the quarter. Citigroup Inc.’s holdings in National Health Investors were worth $4,201,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its position in shares of National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares in the last quarter. Assetmark Inc. grew its holdings in National Health Investors by 19.0% during the 2nd quarter. Assetmark Inc. now owns 925 shares of the real estate investment trust’s stock worth $65,000 after acquiring an additional 148 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in National Health Investors by 24.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,128 shares of the real estate investment trust’s stock worth $90,000 after acquiring an additional 225 shares in the last quarter. Smartleaf Asset Management LLC increased its position in shares of National Health Investors by 212.4% in the 3rd quarter. Smartleaf Asset Management LLC now owns 1,206 shares of the real estate investment trust’s stock worth $95,000 after purchasing an additional 820 shares during the last quarter. Finally, NewEdge Advisors LLC raised its stake in shares of National Health Investors by 28.7% in the 1st quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after purchasing an additional 345 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Price Performance

Shares of NHI opened at $84.80 on Thursday. National Health Investors, Inc. has a 12 month low of $66.41 and a 12 month high of $91.38. The company has a debt-to-equity ratio of 0.76, a current ratio of 6.90 and a quick ratio of 6.90. The stock has a fifty day moving average price of $82.27 and a 200 day moving average price of $78.97. The company has a market cap of $4.10 billion, a P/E ratio of 28.08, a PEG ratio of 4.65 and a beta of 0.65.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). The firm had revenue of $105.82 million for the quarter, compared to analyst estimates of $95.12 million. National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The business’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the firm posted $1.24 EPS. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, research analysts forecast that National Health Investors, Inc. will post 4.41 earnings per share for the current year.

National Health Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Tuesday, March 31st will be given a $0.92 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $3.68 annualized dividend and a yield of 4.3%. National Health Investors’s dividend payout ratio is 121.85%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. KeyCorp lifted their price target on National Health Investors from $80.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. National Bank Financial set a $85.00 target price on National Health Investors in a research report on Tuesday, January 20th. Wells Fargo & Company upped their price target on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th. Truist Financial raised their price objective on National Health Investors from $81.00 to $83.00 and gave the stock a “buy” rating in a research note on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price objective for the company. in a report on Tuesday, January 20th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, National Health Investors currently has an average rating of “Moderate Buy” and a consensus target price of $85.57.

National Health Investors Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.